Integrated Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Integrated Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010914
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company provides product such as xpresys lung that helps physicians to diagnose complex diseases with a non-invasive blood test. Its other products include PET scan, bronchoscopy, needle biopsy, and others. Indi’s xpresys lung is a molecular blood test that offers non-invasive, objective information for the assessment of pulmonary nodules. It concentrates on research and development of diagnostics and measurement technologies used for measuring several bio-markers simultaneously for improved diagnosis and accurate management of complex diseases. Indi is headquartered in Seattle, Washington, the US.

Integrated Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Integrated Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Integrated Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Integrated Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Integrated Diagnostics Raises USD6 Million in Series C Financing 10
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 11
Integrated Diagnostics Raises US$30 Million In Series B Financing 12
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 14
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 15
Partnerships 17
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 17
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 18
Integrated Diagnostics Inc – Key Competitors 19
Integrated Diagnostics Inc – Key Employees 20
Integrated Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Integrated Diagnostics Inc, Medical Equipment, Key Facts 2
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Integrated Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Integrated Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Integrated Diagnostics Raises USD6 Million in Series C Financing 10
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 11
Integrated Diagnostics Raises US$30 Million In Series B Financing 12
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 14
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 15
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 17
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 18
Integrated Diagnostics Inc, Key Competitors 19
Integrated Diagnostics Inc, Key Employees 20

★海外企業調査レポート[Integrated Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iBio Inc (IBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • 7-Eleven Inc:企業のM&A・事業提携・投資動向
    7-Eleven Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 7-Eleven Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • E.ON UK Plc:発電所・企業SWOT分析
    E.ON UK Plc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Plantic Technologies Ltd:企業の戦略的SWOT分析
    Plantic Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • CIMB Group Holdings Berhad:企業のM&A・事業提携・投資動向
    CIMB Group Holdings Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIMB Group Holdings Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Minor International PCL:企業の戦略・SWOT・財務情報
    Minor International PCL - Strategy, SWOT and Corporate Finance Report Summary Minor International PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NetScout Systems, Inc. (NTCT):企業の財務・戦略的SWOT分析
    NetScout Systems, Inc. (NTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • The Dun & Bradstreet Corporation:企業の戦略・SWOT・財務情報
    The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report Summary The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • The Pep Boys – Manny, Moe & Jack of California:企業の戦略的SWOT分析
    The Pep Boys - Manny, Moe & Jack of California - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Aquila Resources Ltd:企業の戦略・SWOT・財務分析
    Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Aquila Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lanxess AG (LXS):企業の財務・戦略的SWOT分析
    Lanxess AG (LXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ImmusanT Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImmusanT Inc (ImmusanT) is a clinical stage biotechnology company that discovers, develops and delivers peptide-based immune therapies for the treatment of patients with autoimmune diseases. The company develops its therapeutic vaccines using its epitope-specific immuno-therapy (ESIT) platfo …
  • C-Rad AB (CRAD B):企業の財務・戦略的SWOT分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • Oman Telecommunications Company SAOG:企業の戦略・SWOT・財務情報
    Oman Telecommunications Company SAOG - Strategy, SWOT and Corporate Finance Report Summary Oman Telecommunications Company SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Beerenberg Corp. AS:企業の戦略的SWOT分析
    Beerenberg Corp. AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Watchstone Group plc (WTG):企業の財務・戦略的SWOT分析
    Summary Watchstone Group plc (Watchstone) formerly Quindell Plc, is a technology company that offers services such as software; consulting and technology enabled outsourcing services. The company provide solutions such as Hubio, pt Health, ingenie, InnoCare, QuoteSupermarket, and others. It provides …
  • Fortis Inc (FTS):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortis Inc (Fortis) is an oil and gas company that provides development of assets and market capitalization programs. The company offers measurement and monitoring of environmental impacts. It also provides capital program and growth plans to meet the energy needs. Fortis support and partici …
  • Waste Management, Inc. (WM):電力:M&Aディール及び事業提携情報
    Summary Waste Management, Inc. (WM) is a provider of waste management environmental services. The company has a presence in waste management vertical from collection, solid and hazardous waste landfills management, transfer, recycling and resource recovery, to disposal. It also develops, operates, a …
  • Starpharma Holdings Ltd (SPL):企業の財務・戦略的SWOT分析
    Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Armstrong World Industries Inc (AWI):企業の財務・戦略的SWOT分析
    Armstrong World Industries Inc (AWI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆